Changhong Zhu Selected Research

Mucinous Cystadenocarcinoma

2/2007	Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the cell proliferation and apoptosis in cells derived from human ovarian mucinous cystadenocarcinoma in Vitro.
1/2006	Effects of antisense oligodeoxynucleotide to follicle-stimulating hormone receptor on the expression of proliferating cell nuclear antigen and vascular endothelial growth factor in primary culture cells derived from human ovarian mucinous cystadenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changhong Zhu Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 04/2010
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021 - 05/2018
3	Male Infertility (Male Sterility) 07/2022 - 04/2013
3	Hyperthermia 01/2021 - 10/2017
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 10/2018
2	Lymphoma (Lymphomas) 03/2019 - 04/2010
2	Carcinogenesis 09/2015 - 04/2015
2	Mucinous Cystadenocarcinoma 02/2007 - 01/2006
1	Fibrosis (Cirrhosis) 01/2022
1	Arrest of spermatogenesis 01/2022
1	Insulin Resistance 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Uterine Hemorrhage (Uterine Bleeding) 01/2021
1	Cryptorchidism (Undescended Testes) 04/2019
1	B-Cell Leukemia (Leukemia, B Cell) 03/2019
1	Wounds and Injuries (Trauma) 10/2018
1	Hemorrhage 10/2018
1	DiGeorge Syndrome (Syndrome, DiGeorge) 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 04/2015
1	Testicular Neoplasms (Testicular Cancer) 04/2010
1	Pain (Aches) 10/2007

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 07/2022 - 07/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2010
3	Polyethylene (Polythene)IBA 10/2018 - 10/2007
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 04/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2013
2	CopperIBA 01/2021 - 10/2007
2	humaninIBA 01/2021 - 01/2021
2	Letrozole (Femara)FDA LinkGeneric 02/2019 - 05/2018
2	Clomiphene (Clomifene)FDA LinkGeneric 02/2019 - 05/2018
2	OligodeoxyribonucleotidesIBA 02/2007 - 01/2006
2	Follicle Stimulating Hormone (Follitropin)FDA Link 02/2007 - 01/2006
2	FSH Receptors (FSH Receptor)IBA 02/2007 - 01/2006
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	VimentinIBA 01/2022
1	CyclinsIBA 01/2022
1	Cyclin B1IBA 01/2022
1	Nucleic AcidsIBA 01/2021
1	Mitogen-Activated Protein Kinase 14IBA 01/2021
1	Cytochromes c (Cytochrome c)IBA 03/2019
1	CaspasesIBA 03/2019
1	Apoptotic Protease-Activating Factor 1IBA 03/2019
1	Dinoprostone (PGE2)FDA Link 10/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2018
1	Hormones (Hormone)IBA 10/2017
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2016
1	Class 4 Receptor-Like Protein Tyrosine PhosphatasesIBA 07/2015
1	src-Family KinasesIBA 07/2015
1	Protein Tyrosine PhosphatasesIBA 04/2015
1	Epidermal Growth Factor (EGF)IBA 04/2015
1	AntigensIBA 04/2010
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006

Therapy/Procedure

2	Intrauterine Devices (Intrauterine Device) 01/2021 - 10/2007